Health Care/Hospital

WuXi PharmaTech Announces Second Quarter 2007 Results

- Net Revenues Up 99% Year-Over-Year SHANGHAI, China, Sept. 5 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) ("WuXi PharmaTech" or "the Company"), the leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its unaudi...

2007-09-06 04:30 930

Boehringer Ingelheim to Initiate First Phase III Pivotal Study for New Oncology Compound BIBW 2992*

New data on BIBW 2992*, a potent, irreversible, second-generation oral signal transduction inhibitor provides glimpse of next chapter in lung cancer care INGELHEIM, Germany, Sept. 6 /Xinhua-PRNewswire/ -- (For non-US Media) Boehringer Ingelheim announced today from the 12th World Conference...

2007-09-06 15:00 697

Joint International Health Partners Statement on Behalf of the GAVI Alliance, Global Fund to Fight AIDS, Tuberculosis and Malaria, Joint United Nations Programme on HIV/AIDS (UNAIDS), UNICEF, United Nations Population Fund, World Bank and the World Health Organization

LONDON, Sept. 5 /Xinhua-PRNewswire/ -- We, as international health partners committed to improving health and development outcomes in the world, welcome and fully support the International Health Partnership’s mission to strengthen health systems, and we congratulate those involved for...

2007-09-05 16:51 751

Roche's Tarceva(R) Delivers Longer Life for Lung Cancer Patients

SEOUL, South Korea, Sept. 5 /Xinhua-PRNewswire/ -- Patients worldwide with advanced lung cancer can expect longer survival according to new data from the TRUST study presented at the 12th World Conference on Lung Cancer (WCLC) in Seoul, Korea. These new worldwide observations show that patients ...

2007-09-05 17:05 834

WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007

Earnings Conference Call to be Held on September 6, 2007 at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Hong Kong) SHANGHAI, China, Sept. 4 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) ("WuXi PharmaTech" or “the Company”), the leading China-based pharmaceutical...

2007-09-04 22:29 913

China Shenghuo Pharmaceutical Holdings, Inc. to Present at Roth 2007 New York Conference

KUNMING, China, Sept. 4 /Xinhua-PRNewswire-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. ("China Shenghuo," "the Company") (Amex: KUN), which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic products in th...

2007-09-04 21:00 1158

WHO Urges Increased Investments and Services for Mental Health

GENEVA, Sept. 4 /Xinhua-PRNewswire/ -- The World Health Organization (WHO) is today appealing to countries to increase their support for mental health services. The appeal is part of a series of six reviews on global mental health which are being published today in the journal The Lancet. WHO ha...

2007-09-04 09:50 700

Media Invitation: Are You Ready for the Next Chapter in Lung Cancer Care?

LONDON, Sept. 4 /Xinhua-PRNewswire/ -- Ready for fresh perspectives on mutational research, future treatment prospects in non-small-cell lung cancer (NSCLC) and a milestone announcement from Boehringer Ingelheim? Learn more at the upcoming international media webcast, 'The second generati...

2007-09-04 16:00 831

China Medical Technologies to Participate in Credit Suisse's 2007 Asian Technology Conference

BEIJING, Sept. 3 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products and high intensity focused ultrasound tumor therapy system...

2007-09-03 18:00 570

Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference

SHENZHEN, China, Aug. 30 /Xinhua-PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that Mr. Xu Hang, Chairman and Co-Chief Executive Office...

2007-08-30 20:00 656

AstraZeneca's Once-Daily SEROQUEL XR(TM) Extended-Release Tablets Approved in Netherlands for the Acute and Long Term Treatment of Schizophrenia

-- For International Medical Journalists Only -- LONDON, Aug. 29 /Xinhua-PRNewswire/ -- AstraZeneca today announced the Netherlands regulatory authority MEB (Medicines Evaluation Board) has approved SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets, a once-daily medicine for ...

2007-08-29 17:41 680

Winner New Product Update: Advanced Dressings and Surgical Gowns

SHENZHEN, China, Aug. 29 /Xinhua-PRNewswire/ -- Winner Medical Group, Inc. ("Winner Medical") (OTC Bulletin Board: WMDG), announces that it has commenced mass production for the orders received from the leading European company to produce advanced dressings. "We believe this marks our high-end...

2007-08-29 20:30 918

China-Biotics, Inc. to Present at Roth 2007 New York Conference

SHANGHAI, China, Aug. 29 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced that Mr. ...

2007-08-29 21:00 684

Phase III Trial Finds Pharmaxis' Bronchitol Effective

SYDNEY, Australia, Aug. 28 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that its Phase III B301 study of Bronchitol for the treatment of people with bronchiectasis has met its two primary efficacy endpoints: quality of life and mucus clearance. Dat...

2007-08-29 09:03 629

Skystar Bio-Pharmaceutical to Present at Roth Capital Partners Conference in New York on September 6, 2007

XI'AN, China, Aug. 28 /Xinhua-PRNewswire-FirstCall/ -- Skystar Bio-Pharmaceutical Co., Ltd. (OTC Bulletin Board: SKBI) ("Skystar", "Company"), a leading bio-pharmaceutical company in the People's Republic of China ("PRC"), today announced that its Director & U.S. Representative, Scott Cramer, ...

2007-08-28 20:00 718

China Medical Technologies Reports First Quarter Financial Results

Robust IVD Revenue Exceeded HIFU Revenue FY2007 Annual Targets Under Review BEIJING, Aug. 28 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced i...

2007-08-28 18:00 718

China Biologic Products, Inc. to Present at Roth Capital Partners Conference in New York on September 5, 2007

TAI'AN CITY, China, Aug. 28 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (CBPO.PK), one of leading plasma-based pharmaceutical company in the People's Republic of China (“PRC”), today announced that its Chief Executive Officer, Stanley Wong will present at the upcoming Roth C...

2007-08-28 20:00 559

China Medicine Corp. to Present at 5th Annual Roth New York Conference on September 6 at 9:00 a.m.

GUANGZHOU, China, Aug. 27 /Xinhua-PRNewswire-FirstCall/ -- China Medicine Corporation ("CMC") (OTC Bulletin Board: CHME), a leading distributor of prescription and over the counter pharmaceutical products, traditional Chinese medicines, Chinese herbs, nutritional supplements, dietary supplements...

2007-08-28 01:09 654

Synutra International, Inc. Receives Nasdaq Staff Determination Letter

QINGDAO, China and ROCKVILLE, MD, USA, Aug. 24 /Xinhua-PRNewswire/ -- Synutra International, Inc. (Nasdaq: SYUT; "Synutra"), one of China's leading manufacturers of dairy-based nutritional products for infants, children and adults, has received a staff determination letter from The Nasdaq Stock ...

2007-08-25 05:32 893

WuXi PharmaTech CEO Appointed to CrossFire Beilstein Database Advisory Board

SHANGHAI, China, Aug. 24 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), China's premier provider of pharmaceutical R&D outsourcing services announced today Dr. Ge Li, the Company's Chairman and Chief Executive Officer, is appointed to a newly established advisory board of Elsevier Informatio...

2007-08-24 20:05 1130
1 ... 865866867868869870871 ... 885